We are live on ! Find out more
GTBP icon

GT Biopharma
GTBP

49 hedge funds and large institutions have $69.7M invested in GT Biopharma in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,653% more capital invested

Capital invested by funds: $3.98M → $69.7M (+$65.7M)

725% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 4

145% more funds holding

Funds holding: 20 → 49 (+29)

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

0.62% more ownership

Funds ownership: 0.09% → 0.71% (+0.62%)

Holders
49
Holders Change
+29
Holders Change %
+145%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
9
Reduced
4
Closed
4
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
+$9K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$19.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$9.9M
3
Citadel Advisors
Citadel Advisors
Florida
+$7.06M
4
State Street
State Street
Massachusetts
+$5.19M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$3M

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$290K
2
Millennium Management
Millennium Management
New York
-$191K
3
VF
Virtu Financial
New York
-$156K
4
Squarepoint
Squarepoint
New York
-$113K
5
TRCT
Tower Research Capital (TRC)
New York
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$21.9M +$19.6M +47,113 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$15.2M +$9.9M +23,820 +267%
Citadel Advisors
3
Citadel Advisors
Florida
$7.91M +$7.06M +17,002 New
State Street
4
State Street
Massachusetts
$5.81M +$5.19M +12,490 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$5.37M +$3M +7,208 +166%
Northern Trust
6
Northern Trust
Illinois
$3.5M +$2.65M +6,369 +556%
SCP
7
Silverleafe Capital Partners
Tennessee
$1.61M +$1.44M +3,467 New
N
8
Nuveen
North Carolina
$1.27M +$1.14M +2,738 New
Bank of New York Mellon
9
Bank of New York Mellon
New York
$910K +$813K +1,957 New
Charles Schwab
10
Charles Schwab
California
$899K +$803K +1,933 New
IEFM
11
IQ EQ Fund Management
Ireland
$544K +$122K +293 +33%
Morgan Stanley
12
Morgan Stanley
New York
$540K +$446K +1,074 +1,234%
California State Teachers Retirement System (CalSTRS)
13
California State Teachers Retirement System (CalSTRS)
California
$510K +$455K +1,096 New
Marshall Wace
14
Marshall Wace
United Kingdom
$400K +$357K +860 New
CCM
15
Conway Capital Management
California
$318K +$20.8K +50 +8%
New York State Common Retirement Fund
16
New York State Common Retirement Fund
New York
$316K +$283K +680 New
RhumbLine Advisers
17
RhumbLine Advisers
Massachusetts
$289K +$258K +621 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$275K +$246K +591 New
Deutsche Bank
19
Deutsche Bank
Germany
$237K +$213K +512 New
CLOS
20
Compagnie Lombard Odier SCmA
Switzerland
$233K +$208K +500 New
Two Sigma Advisers
21
Two Sigma Advisers
New York
$231K +$207K +497 New
Manulife (Manufacturers Life Insurance)
22
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$213K +$191K +459 New
MIM
23
MetLife Investment Management
New Jersey
$178K +$159K +382 New
Invesco
24
Invesco
Georgia
$167K +$149K +359 New
JP Morgan Chase
25
JP Morgan Chase
New York
$142K +$127K +305 New
1
2 3

GTBP Hedge Fund Activity: Q2 2021 in Review

49 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GT Biopharma (GTBP) for Q2 2021, worth a combined $69.7M — up 1,653% from $3.98M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new GTBP positions and 4 closed out — a net gain of 29 holders — while 9 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $19.6M. The largest seller was Royal Bank of Canada, cutting an estimated $290K.

  • 49 institutional investors held GT Biopharma (GTBP) as of Q2 2021, up from 20 in Q1 2021.
  • Funds reported $69.7M of GT Biopharma stock for Q2 2021, up 1,653% quarter-over-quarter.
  • 33 funds opened new GT Biopharma positions in Q2 2021 and 4 closed out, a net change of +29 holders.
  • The largest GT Biopharma buyer in Q2 2021 was BlackRock, an estimated $19.6M added.
  • The largest GT Biopharma seller in Q2 2021 was Royal Bank of Canada, an estimated $290K sold.

Based on aggregated 13F filings for Q2 2021.